# Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)

> **NCT06774807** · NA · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **OTHER:** Saline infusion
- **OTHER:** Saline injection
- **OTHER:** 1nmol antagonist infusion
- **OTHER:** 4 nmol antagonist infusion
- **OTHER:** Agonist injection

## Key facts

- **NCT ID:** NCT06774807
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06774807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06774807, "Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06774807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*